|By Marketwire .||
|September 20, 2012 06:30 AM EDT||
TORONTO, ONTARIO -- (Marketwire) -- 09/20/12 --
Attention: Business/Financial Editors
The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), an award-winning leader in the development and commercialization of healthcare solutions that positively impact people's lives through the prevention of disease and analysis of medical images and data, announced today that its mHealth Business Unit has shipped SMARTCOACH(TM) to Zwanger-Pesiri Radiology, one of the largest private radiology practices in New York. The practice is providing SMARTCOACH to its 600 employees to guide them toward their fitness and health goals. Zwanger-Pesiri is a leader in offering ground breaking imaging technology, innovative patient care, and commitment to the wellness of its employees.
"Zwanger-Pesiri has a strong relationship with Medipattern through both the B-CAD® program and now Visualize:Vascular(TM). When Medipattern introduced us to the SMARTCOACH system, we were immediately impressed. SMARTCOACH is not a step counter. It is a health coach that guides you to achieve both fitness and health goals. It monitors individuals to see the intensity of their activity and coaches them toward obtaining their individual goals. SMARTCOACH has a wearable component which actively lets you see if you are achieving your goals in real time and then it coaches you. It logs your activity showing you times where you can improve and suggests activities that can get the most out of your activity. It coaches all of us individually on fitness, nutrition and health making meaningful suggestions to each of us. SMARTCOACH also allows us to create a circle of care, where we can message each individual or groups of users within our private group to help motivate them and keep them on track," commented Dr. Steven Mendelsohn, president of Zwanger-Pesiri Radiology.
"Radiologists see that Metabolic Syndrome is growing at an alarming rate. The syndrome's key indicators are obesity or extra weight around the middle, high blood pressure, high triglycerides, and low HDL. We know the long term effects are increased risk to Type 2 Diabetes, Cardiovascular Disease and Stroke all of which impact a person's quality of life years before causing death. The main way to combat the syndrome is with diet and exercise. We generally site these concerns when reviewing patients, but we also need to look at ourselves. That is why we are joining the SMARTCOACH program and giving the device to everyone on our staff who will commit to making a change to live better. The next step will be engaging our patients to become proactive in preventing Metabolic Syndrome to get them moving towards a healthier future," concluded Dr. Mendelsohn.
"Zwanger-Pesiri brings outstanding care to their community with leading edge imaging technologies and innovative wellness programs. We are very pleased to be a part of their upcoming Wellness Fair on September 30th carrying their message about fitness and health to their community," commented Jeff Collins, CEO of Medipattern. "We are also very pleased to be partnering with Zwanger-Pesiri to address the most rapidly growing health problem in the United States: Metabolic Syndrome. Everyone at Zwanger-Pesiri will be participating in the SMARTCOACH program. The data will be used to report on the benefits of SMARTCOACH, allowing us to demonstrate its benefits to much larger groups and other practices."
About the Medipattern Corporation:
Medipattern® is an award-winning leader in the development and commercialization of healthcare solutions that positively impact people's lives through the prevention of disease and analysis of medical images and data. Medipattern's Knowledge-based Informatics (MKI) platform enables delivery of these streamlined solutions. Medipattern mHealth uses patented prevention technologies to engage, coach and monitor people in achieving their personalized goals. Medipattern iaHealth uses patented pattern recognition technology to analyze medical data to aid medical practitioners in the assessment of disease and critical anatomy. For more information, please visit the Company's website: www.medipattern.com.
Medipattern® and B-CAD® are registered trademarks of The Medipattern Corporation. Visualize:Vascular(TM) is a registered trademark of Medipattern and SMARTCOACH(TM) is a trademark of MYTRAK Health Systems and will be under temporary license to Medipattern while the company reviews branding.
This document contains forward-looking statements relating to Medipattern's performance, operations, or business environment. These statements are based on what we believe are reasonable assumptions given currently available information and our understanding of Medipattern's current activities. We have tried, whenever possible, to identify these forward-looking statements using words such as "anticipates,'' "believes,'' "estimates,'' "expects,'' "plans,'' "intends,'' "potential'', and similar expressions. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict or control. A number of factors could cause actual outcomes and results to differ materially from those expressed in forward-looking statements. These factors include but are not limited to those set forth in the Company's corporate filings, (posted at www.sedar.com). These factors should be considered carefully, and readers should not place undue reliance on Medipattern's forward-looking statements. In addition, these forward-looking statements relate to the date on which they are made. The Company disclaims any intention or obligation to update or revise any forward-looking statements for any reason. Readers should not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.